Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection
Clinical trial NCT01780831 · COMPLETED
Trial details
- NCT number
- NCT01780831
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-28
- Primary completion
- 2017-12-14
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.